Drugs / BenFin
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT00026117 | Aug 2001 → Sep 2006 | breast cancer, colorectal cancer | Alliance for Clinical Trials in Oncology | Completed | Missed primary |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | BenFin | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00026117 ↗ |
| Known as | BeneFin | “Patients receive oral shark cartilage (BeneFin™) 3-4 times daily.” NCT00026117 ↗ |
| Route | Oral | “Patients receive oral shark cartilage (BeneFin™) 3-4 times daily.” NCT00026117 ↗ |